Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-06-26 Sale | 2024-06-27 8:00 pm | KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 15,168 | $4.75 | $72,048 | 263,755 (Direct) | View |
2024-05-31 Sale | 2024-06-03 8:00 pm | KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 7,392 | $6.09 | $45,017 | 278,923 (Direct) | View |
2024-01-04 Sale | 2024-01-05 4:04 pm | KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 4,539 | $6.73 | $30,547 | 350,815 (Direct) | View |
2023-01-04 Sale | 2023-01-06 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 198 | $28.54 | $5,651 | 45,966 (Direct) | View |
2022-10-26 Sale | 2022-10-28 4:15 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 561 | $6.52 | $3,658 | 4,464 (Direct) | View |
2022-06-27 Sale | 2022-06-29 8:09 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 7,975 | $0.37 | $2,951 | 251,183 (Direct) | View |
2022-01-04 Sale | 2022-01-05 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 9,518 | $1.3 | $12,373 | 1,034,158 (Direct) | View |
2021-10-26 Sale | 2021-10-28 8:01 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 27,598 | $1.8 | $49,676 | 268,676 (Direct) | View |
2021-06-28 Sale | 2021-06-29 5:25 pm | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 7,586 | $5.77 | $43,771 | 296,274 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-08 Option Award | 2024-06-11 5:28 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 26,000 | $0 | 26,000 (Direct) | View |
2024-06-06 Option Award | 2024-06-10 4:24 pm | N/A 2034-06-05 | Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director | 20,000 | $0 | 20,000 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 6:00 pm | N/A 2034-06-04 | Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director | 12,500 | $0 | 12,500 (Direct) | View |
2024-05-07 Option Award | 2024-05-09 4:30 pm | N/A 2034-05-07 | Merus N.V. | MRUS | Iwicki Mark T Director | 8,844 | $0 | 8,844 (Direct) | View |
2024-03-25 Option Award | 2024-03-27 5:40 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | Iwicki Mark T Director | 25,534 | $0 | 25,534 (Direct) | View |
Ownership | 2024-03-27 5:16 pm | N/A 2031-01-21 | Q32 Bio Inc. | QTTB | Iwicki Mark T Director | 0 | $0 | 44,837 (Direct) | View |
2024-01-04 Option Award | 2024-01-05 4:04 pm | N/A 2034-01-03 | KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 78,800 | $0 | 350,815 (Direct) | View |
2023-06-23 Option Award | 2023-06-27 5:39 pm | N/A 2033-06-22 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 15,000 | $0 | 15,000 (Direct) | View |
2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 370,704 | $0 | 488,385 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:16 pm | N/A 2033-06-08 | Merus N.V. | MRUS | Iwicki Mark T Director | 14,414 | $0 | 14,414 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:00 pm | N/A 2033-06-05 | Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director | 12,500 | $0 | 12,500 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:18 pm | N/A 2033-06-05 | Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director | 16,250 | $0 | 16,250 (Direct) | View |
2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2025-06-03 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 71,715 | $0 | 117,681 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 71,715 | $0 | 117,681 (Direct) | View |
2023-04-14 Exercise | 2023-04-17 08:26 am | N/A N/A | Merus N.V. | MRUS | Iwicki Mark T Director | 36,944 | $6.57 | 73,576 (Direct) | View |
2023-04-14 Exercise | 2023-04-17 08:26 am | N/A N/A | Merus N.V. | MRUS | Iwicki Mark T Director | 36,632 | $7.97 | 73,576 (Direct) | View |
2023-04-14 Exercise | 2023-04-17 08:26 am | N/A 2023-06-02 | Merus N.V. | MRUS | Iwicki Mark T Director | 73,576 | $0 | 73,576 (Direct) | View |
2023-03-14 Option Award | 2023-03-15 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 1,512 | $0 | 1,512 (Direct) | View |
2023-03-06 Disposition | 2023-03-08 5:02 pm | N/A 2032-02-16 | Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director | 49,080 | $0 | 49,080 (Direct) | View |
2023-03-06 Option Award | 2023-03-08 5:02 pm | N/A 2032-02-16 | Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director | 49,080 | $0 | 49,080 (Direct) | View |
2023-01-04 Option Award | 2023-01-06 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 41,700 | $0 | 45,966 (Direct) | View |
2022-10-26 Option Award | 2022-10-27 4:55 pm | N/A 2032-10-25 | Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director | 13,667 | $0 | 13,667 (Direct) | View |
Ownership | 2022-09-14 6:08 pm | N/A N/A | Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director | 0 | $0 | 168,343 (Direct) | View |
2022-06-21 Option Award | 2022-06-22 5:00 pm | N/A 2032-06-20 | Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director | 12,500 | $0 | 12,500 (Direct) | View |
2022-06-02 Option Award | 2022-06-03 4:06 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 15,000 | $0 | 15,000 (Direct) | View |
2022-05-31 Option Award | 2022-06-02 4:05 pm | N/A 2032-05-31 | Merus N.V. | MRUS | Iwicki Mark T Director | 16,604 | $0 | 16,604 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 775,000 | $0 | 1,034,158 (Direct) | View |
2021-04-02 Option Award | 2021-07-01 6:33 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director | 158,497 | $0 | 158,497 (Direct) | View |
Ownership | 2021-06-29 7:41 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director | 0 | $0 | 116,297 (Direct) | View |
2021-06-01 Option Award | 2021-06-03 5:58 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 13,000 | $0 | 13,000 (Direct) | View |
2021-05-28 Option Award | 2021-06-02 4:10 pm | N/A 2031-05-28 | Merus N.V. | MRUS | Iwicki Mark T Director | 6,120 | $0 | 6,120 (Direct) | View |
2021-01-28 Option Award | 2021-02-01 9:45 pm | N/A 2031-01-28 | Pulmatrix Inc. | PULM | Iwicki Mark T Director | 15,000 | $0 | 15,000 (Direct) | View |
2021-01-04 Option Award | 2021-01-05 4:50 pm | N/A 2031-01-03 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer | 379,000 | $0 | 606,860 (Direct) | View |
2020-10-26 Option Award | 2020-10-28 8:24 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer | 178,300 | $0 | 227,860 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 17,500 | $16.24 | 0 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 39,567 | $34.5 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 19,755 | $19.1 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 7,840 | $34.5 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 52,421 | $31.48 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 15,398 | $17.39 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 87,368 | $28.21 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 7,500 | $1.71 | 0 (Direct) | View |
2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 11,432 | $14.6 | 0 (Direct) | View |
2020-06-30 Option Award | 2020-07-02 4:00 pm | N/A 2030-06-30 | Merus N.V. | MRUS | Iwicki Mark T Director | 8,631 | $0 | 8,631 (Direct) | View |
2020-06-25 Option Award | 2020-06-29 9:52 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer | 49,560 | $0 | 49,560 (Direct) | View |
2020-06-01 Option Award | 2020-06-02 6:54 pm | N/A 2030-05-31 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 13,000 | $0 | 13,000 (Direct) | View |